Last updated: 11/07/2018 17:05:40
Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma.
Trial description: Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Bidat E, Kolta S, Desfougères JL, Minini P, Roux C. ERS Stockholm 2002. Equivalent bone safety and better efficacy of fluticasone propionate compared to nedocromil sodium in asthmatic children. Results of a 2-year randomised study. Eur Respir J 2002; Abs1443.
Roux C, Kolta S, Desfougères JL, Minini P, Bidat E. Fluticasone Propionate is as Safe as Nedocromil Sodium on Bone Mineral Density and More Effective in Asthmatic Children. ATS 2002 Atlanta. Am J Respir Crit Care Med 2002; suppl : A744 absB32.
Roux C, Kolta S, Desfougères JL, Minini P, Bidat E. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003. 111 (6 pt 1) e706-713.
Roux C, Kolta S, Desfougères JL, Minini P, Bidat E. Tolerance Osseuse équivalente et efficacité supérieure du propionate de fluticasone par rapport au nédocromil dans l’asthme de l’enfant. SFP (Société Française de Pédiatrie) Montpellier 2002. Arch Pediatr 2002; 9 suppl 2:303S-303S, AbsC053.
Medical condition
Asthma
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
June 1996 to Invalid Date
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
Not applicable
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website